Information and opinions presented here do not always represent the views of the American Heart Association.

All posts tagged Rose Marie Robertson

Patients should talk to doctors before changing dosage on anti-clotting drug

A recent report questions whether more could be done to prevent side-effects and improve effectiveness of the anti-clotting drug dabigatran, but medical experts urge people to continue taking the medication as prescribed unless their physician says otherwise. The drug, sold …

Continue Reading...
woman with doctor

First set of recommendations in a decade advocate gender-specific approach for women

A more gender-specific approach should be used in diagnosing heart disease, according to the first set of guidelines in about a decade by the American Heart Association on women’s ischemic heart disease. The

Rose Marie Robertson

FDA hearing highlights research gaps for women, minorities and the elderly

Rose Marie Robertson, M.D., Chief Science Officer of the American Heart Association, testified at a Food and Drug Administration public hearing Tuesday to address gaps in how certain